Matinas Biopharma Holdings, Inc. (NYSEAMERICAN:MTNB – Get Free Report) was the target of a significant drop in short interest in the month of January. Matinas Biopharma Trading Up 0.7%NYSEAMERICAN MTNB traded up $0.01 during trading on Wednesday, reaching $0.73. Matinas Biopharma has a 12 month low of $0.47 and a 12 month high of $3.09. Get Matinas Biopharma alerts:Matinas Biopharma (NYSEAMERICAN:MTNB – Get Free Report) last released its quarterly earnings results on Monday, November 10th. Featured StoriesReceive News & Ratings for Matinas Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Matinas Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.